Related Experiment Video
Updated: Dec 11, 2025
09:00
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
8.5K
CRISPR-Cas9 Applications in Cardiovascular Disease
John Paul S Khouzam1, Vijai S Tivakaran2
1University of Notre Dame, Neuroscience and Behavior Undergraduate, Notre Dame, Indiana.
Current Problems in Cardiology
|August 24, 2020
Summary
CRISPR-Cas9 gene editing offers a powerful tool for cardiovascular disease research, enabling targeted gene modification. While promising, technical and ethical considerations remain for its clinical application in cardiology.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- CRISPR-Cas9, a bacterial immune system, is a revolutionary gene-editing tool.
- Its efficiency and simplicity allow for precise genome modification in various cell types (in vitro/in vivo, germline/somatic).
- Applications include knocking out harmful genes or knocking in beneficial ones.
Purpose of the Study:
- To review the current state of CRISPR-Cas9 research in cardiovascular disease.
- To explore potential novel applications of CRISPR-Cas9 in cardiology.
Main Methods:
- Literature review of CRISPR-Cas9 applications in cardiovascular research.
- Analysis of current research trends and future prospects.
Main Results:
- CRISPR-Cas9 is being utilized to address specific mutations causing cardiovascular diseases.
- Research highlights the system's potential for gene knockout and knock-in strategies.
Conclusions:
- CRISPR-Cas9 holds significant promise for advancing cardiovascular disease treatment and research.
- Further investigation into technical limitations and ethical implications is crucial for human application.
Related Concept Videos
01:59CRISPR
56.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
56.6K
01:28CRISPR/Cas9 Genome Editing
1.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.4K
02:53CRISPR and crRNAs
18.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.5K
02:31Homologous Recombination
61.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
61.7K